Comparative Study Between Wide Local Excision and Minimal Excision of Pilonidal Sinus
Launched by ABANOUB EMAD FAYEZ · Aug 28, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for treating a condition called pilonidal sinus, which is a painful issue that can occur in the area near the tailbone. The trial will compare a larger surgery called wide local excision with a smaller surgery known as minimal excision to see which one works better for patients.
If you’re between the ages of 18 and 75 and are experiencing this condition for the first time or have had it come back after a smaller surgery, you might be eligible to participate. Participants in the trial can expect to receive one of the two types of surgery and will be monitored to see how well they heal and how effective each method is in preventing future problems. Please note that individuals who have had a larger surgery before will not be included in this study. This trial aims to help determine the best approach for treating pilonidal sinus, which could improve care for many patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients complaining of primary PNS and Recurrent PNS following Minimal excision
- Exclusion Criteria:
- • Recurrent PNS following wide local excision
About Abanoub Emad Fayez
Abanoub Emad Fayez is a dedicated clinical trial sponsor with expertise in the design and management of innovative medical research studies. Committed to advancing healthcare, Fayez focuses on ensuring rigorous adherence to ethical standards and regulatory compliance throughout the trial process. With a background in clinical research and a strong emphasis on patient safety and data integrity, he collaborates with multidisciplinary teams to facilitate the development of new therapies and interventions. Fayez’s proactive approach and strategic insight contribute to the successful execution of clinical trials, ultimately aiming to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported